Kayog, Tayanor K.
HRN: 22-49-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2024
CEFUROXIME 1.5GM (VIAL)
08/06/2024
08/06/2024
IV
1500mg
Single Dose On Call To OR
Cesarean Section
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes